Big Gain For Jounce Therapeutics, Inc.

Wed, Mar 15, 2023 at 07:06 PM
Big Gain For Jounce Therapeutics, Inc.

Jounce Therapeutics, Inc. (JNCE:NASDAQ) jumped higher at $1.49, representing a gain of 40.6%. On Wed, Mar 15, 2023, JNCE:NASDAQ hit a New 2-Week High of $1.49. The stock appeared on our News Catalysts scanner on Sat, Mar 11, 2023 at 10:06 AM in the 'MISCELLANEOUS' category. From Wed, Mar 01, 2023, the stock recorded 40.00% Up Days and 54.55% Green Days

About Jounce Therapeutics, Inc. (JNCE:NASDAQ)

Jounce Therapeutics Inc is a clinical stage immunotherapy company. It is engaged in transforming the treatment pf cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.